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E-mail address: suess@bio.uni-frankfurt.de (B. SueRiboswitches are natural RNA-based genetic switches that sense small-molecule metabolites and
regulate in response the expression of the corresponding metabolic genes. Within the last years, sev-
eral engineered riboswitches have been developed that act on various stages of gene expression.
These switches can be engineered to respond to any ligand of choice and are therefore of great inter-
est for synthetic biology. In this review, we present an overview of engineered riboswitches and dis-
cuss their application in conditional gene expression systems. We will provide structural and
mechanistic insights and point out problems and recent trends in the development of engineered
riboswitches.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Oneof themost interesting scopes of synthetic biology is the con-
trol of cellular behaviour with genetic circuits. Genes with selected
features are combined in a building-block manner and conveyed to
organisms of interest to achieve desired biological functions. There-
by, researchers take advantage of a fast-growing repertory of char-
acterised genes due to the progress in DNA synthesis and
sequencing technologies. Over the last years, synthetic biology has
achieved remarkable results in producing useful substances such
as biofuels or drugs, generating biochemical sensor systems or in
biomedical applications [1].
A milestone in synthetic biology came from the Keasling lab.
They used genes of several species and engineered metabolic path-
ways for the synthesis of artemisinic acid, a precursor of the
antimalaria drug artemisinin [2,3]. With this approach, they
avoided the efforts of chemical synthesis and exploited Escherichia
coli and Saccharomyces cerevisiae as bioreactors instead. As a
further example, Collins and co-workers tackled the rising bio-
ﬁlm-mediated resistance of bacteria in medical and industrial
institutions [4]. They optimized lytic bacteriophages for fast repli-
cation and armed them with dispersin B, a bioﬁlm-degrading en-
zyme originating from Actinobacillus actinomycetemcomitans.al Societies. Published by Elsevier
ss).Lysis of the infected bacteria released new phages and dispersin
B, thereby killing in a cyclic process 99.997% of the bacterial cells
in the treated bioﬁlms. In an approach from the Li lab, bacteria
were reprogrammed to knock down the tumour-initiating CTNNB1
gene after intravenous injection into a tumour mouse model [5].
Along with a shRNA targeting CTNNB1, the engineered bacteria
were equipped with the cell-invasion permitting inv gene from
Yersinia pseudotuberculosis and the hlyA gene from Listeria monocyt-
ogenes, which facilitates uptake of genetic material.
The basic genetic elements that are required to build genetic
circuits (such as promoters, Shine-Dalgarno (SD) sequences, coding
sequences and terminators) have been characterised and regis-
tered as standardised BioBrick parts to make the engineering pro-
cess of desired biologic functions easier and faster [6]. However,
the single components of the genetic circuit have to be chosen
and assembled thoroughly. The expression level of the correspond-
ing genes must be regulated and ﬁne-tuned precisely to avoid
unbalanced gene expression, accumulation of toxic intermediates
and to minimise phenotypic noise. The phenomenon of phenotypic
noise is described as variation within an isogenic population due to
ﬂuctuations in gene expression of single cells [7,8]. In prokaryotes,
an increased translation efﬁciency is the main contributor to phe-
notypic noise, whereas processes affecting transcription initiation
such as chromatin remodelling seem to be responsible in eukary-
otes [9,10]. In order to obtain suitable levels of gene product, ge-
netic regulatory systems operating both on transcriptional and
posttranscriptional level are needed.B.V. Open access under CC BY-NC-ND license.
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nations of promoters and enhancers [11,12]. Inducible promoters
have been used to generate complex genetic circuits with diverse
operation modes such as autoregulatory feedback loops, toggle
switches, Boolean logic gates and oscillators [13,14]. Furthermore,
the transcription level of inducible promoters can be adjusted by
using compounds that are chemically related to the inducer mole-
cule [15].Whereas systems for transcriptional control are numerous
andwell studied, only few systems exist for posttranscriptional reg-
ulation. RNAi has proven to be a powerful tool acting either on trans-
lation inhibition or RNA degradation [5,16]. An interesting newway
in regulating gene expression is represented by RNA-editing [17].
The idea here is that the sequence of a transcript can be transiently
changed on RNA level. The genetic information, however, remains
unaltered. The efﬁciency of translation initiation in bacteria can be
addressed by altering the SD sequence, therebymodifying the afﬁn-
ity of the 30S ribosomal subunit [10]. On protein level, gene expres-
sion can bemodulated using translational fusionswith destabilizing
peptide tags or by regulated proteolysis [18–20]. Collins and co-
workers combined transcriptional and posttranscriptional control
using inducible promoters and shRNA expression to generate a
modular genetic circuit inmammals that offers >99% repression, re-
duced leakiness and possesses a tuneable, reversible control of gene
expression [21].
As synthetic biology begins to create more realistic and complex
systems, an expanded set of genetic switches is demanded. Within
the last years, a new class of synthetic devices, engineered ribos-
witches, came into focus. Natural riboswitches represent a recently
discovered class of genetic regulatory elements that are widesprea-
dly distributed over the phylogeny of bacteria and act on transcrip-
tional or posttranscriptional level [22–24]. They consist of
structured RNA elements and reside mostly in the untranslated re-
gions (UTR) of metabolic genes. Riboswitches are comprised of two
domains, a sensing domain (also called aptamer domain) and a
regulating domain (called expression platform). Binding of a
metabolite to the aptamer domain results in a conformational
change within the expression platform thereby affecting the
expression of the corresponding gene. In most cases, riboswitches
operate via attenuating transcription termination or interfering
with translation initiation (Fig. 1A and B), but examples of ribos-
witches controlling RNA degradation or the production of an anti-
sense transcript have been reported as well [25,26]. Based on the
principles of riboswitch regulation, a versatile set of engineered
riboswitches has been developed by the combination of RNA-based
sensing and regulating domains.
In this review, we give an overview of engineered riboswitches
and their applications for conditional gene expression. We provide
an insight into their mechanism and consider problems and future
perspectives.
2. RNA tools to create engineered riboswitches
Engineered riboswitches known so far exploit RNA aptamers as
core component. Aptamers are small nucleic acid molecules capa-
ble of binding nearly any ligand of choice with high afﬁnity and
speciﬁcity. They are generated by directed evolution (SELEX: sys-
tematic evolution of ligands by exponential enrichment), an in vitro
technology invented about a decade before the discovery of natural
riboswitches [27,28]. In SELEX, a pool of usually 1014 randomized
sequences is mixed with an immobilized target. Non-binding
molecules are removed by washing whereas bound molecules are
speciﬁcally eluted, ampliﬁed and subjected to further rounds of
selection. Gradually increasing the stringency during the following
cycles can lead to aptamers that bind with afﬁnities in the
picomolar range and discriminate between closely relatedcompounds. Automated SELEX has sped up the generation process
and allows high-throughput applications [29–31]. Aptamers
against a plethora of different ligands have been generated includ-
ing ions, organic compounds such as amino acids or antibiotics,
proteins, viruses and even whole cells [32].
Aptamers often adopt their ﬁnal three-dimensional structure
only upon ligand binding [33]. Therefore, an aptamer can be both
a sensing and regulating domain. Similar to natural riboswitches,
the ligand induced conformational change of an aptamer can inter-
fere with different steps of gene expression. Only few selected
aptamers, however, make sufﬁcient conformational rearrange-
ments to apply them successfully as riboswitch (see Section 4).
Catalytic RNAs, so-called ribozymes, represent alternative regu-
lating domains [34]. The fusion of aptamers and ribozymes gener-
ates aptazymes (aptamer + ribozyme) with the catalytic activity of
the ribozyme being allosterically regulated by the aptamer [35].
Using self-cleaving RNAs, one is able to control the cleavage rate
of the ribozyme in a ligand dependent manner and, by integrating
the aptazyme into a cellular RNA of interest, also the degradation
rate of the targeted RNA. Apparently, the way how aptamers and
ribozymes are linked deﬁnes how efﬁcient an aptazyme operates
and whether ligand binding induces or represses ribozyme activity.
Suitable linker sequences, often also termed as communication
modules, are identiﬁed using randomized linker domains and
applying SELEX [36]. Aptazymes can also be designed by rational
design; however, one requires detailed knowledge about the struc-
ture and function of the respective domains.
3. Applications for engineered riboswitches
3.1. Small molecule binding aptamers control translation
initiation in eukaryotes
The ﬁrst example of an in vitro selected aptamer being used in
controlling gene expression made a decisive contribution in devel-
oping RNA-mediated genetic control devices. Werstuck and Green
incorporated aptamers against a Hoechst dye into the 50-UTR of a re-
porter gene. They observed that, when transfected in mammalian
cells, translation was repressed in presence of the dye (Fig. 1C)
[37]. With this study, they showed for the ﬁrst time that structural
RNA elements are tightened upon binding of a ligand and thereby
interfere as an inhibitory complex with the ribosome.
Inspired by this roadblock mechanism, we used a tetracycline
binding aptamer to regulate translation initiation in yeast (Fig. 2A)
[38,39]. In the 50-UTR, the aptamer-tetracycline complex inhibits
binding of the small ribosomal subunit when integrated close to
the cap structure and the assembly of the 80S ribosome when in-
serted directly upstream of the translational start site, respectively.
Interestingly, insertions near the start codon showed a more efﬁ-
cient regulation than cap-proximal insertions. Furthermore, using
tetracycline aptamers in tandem strongly increases the dynamic
range of regulation and permits the control of essential genes in
yeast [40]. In a similar approach, we used a neomycin aptamer,
the smallest riboswitch known so far (Fig. 2B) [41]. Other groups
successfully exploited malachite green, theophylline and biotin
aptamers to control translation initiation in wheat germ and reticu-
locyte extracts, yeast or Xenopus oocytes [42,43].
3.2. Small molecule binding aptamers control pre-mRNA splicing
Affecting splicing of eukaryotic pre-mRNAs represents an alter-
native way in controlling gene expression with engineered ribos-
witches (Fig. 1D). Placing an aptamer near sequences essential
for splicing such as the 50 splice site (50-SS), branch point or 30-SS
has been used to impair the efﬁciency of splicing, thereby reducing
Fig. 1. Common regulation mechanisms of natural and engineered riboswitches. Natural riboswitches: (A) Regulation of translation initiation: In the absence of the
metabolite, a stem loop structure is formed between the aptamer and the expression platform (2 + 3). The SD sequence is accessible for 30S binding and translation initiation
occurs. Metabolite binding favours the formation of alternative stem loop structures (1 + 2 and 3 + 4) that sequester the SD sequence. The 30S subunit cannot bind and
translation initiation is inhibited. (B) Regulation of transcription termination: Metabolite binding triggers the formation of a terminator stem loop structure and thereby
terminates transcription. Noteworthy, there also exist natural riboswitches that activate transcription and translation upon metabolite binding. Engineered riboswitches: (C)
An aptamer is inserted in the 50-UTR of a eukaryotic mRNA. In the absence of the ligand, 43S scanning occurs until the ﬁrst AUG is reached and translation is initiated. The
formation of a stable ligand-aptamer complex disturbs 43S scanning and decreases the rate of translation initiation. (D) Regulation of pre-mRNA splicing: An aptamer is
integrated into an intron of a eukaryotic mRNA to control the accessibility of essential splice elements. Ligand binding either inhibits splicing or enhances exon skipping. (E)
Control of translation initiation in bacteria: An aptamer is inserted via a communication module (red) directly upstream of the SD sequence and thereby inhibits translation
initiation due to its close proximity. Ligand binding induces a conformational change within the communication module and shifts the aptamer away from the SD sequence.
(F) Control of gene expression with catalytic riboswitches: A self-cleaving aptazyme is inserted in the 50- or 30-UTR of an eukaryotic mRNA. Ligand induced self-cleavage
removes mRNA-stabilizing elements such as the 50-cap and the poly(A) tail, respectively, and triggers RNA degradation via exoribonucleases (blue pacmans). In bacteria,
catalytic riboswitches are used to liberate a sequestered SD sequence upon ligand induced self-cleavage.
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amer (Fig. 2C) close to the 30-SS and observed a 4-fold reduction
of gene expression in an in vitro splicing assay upon addition of
theophylline [44]. We targeted the 50-SS with the tetracycline apt-
amer to regulate splicing in yeast [45]. We inserted the aptamer in
a way that the consensus sequence of the 50-SS is integrated within
the closing stem of the aptamer (P1 in Fig. 2A) and accessible for
the U1-snRNP only in the absence of tetracycline. Here, a dynamic
range of regulation up to 16-fold was achieved using the more sta-
ble minimer version I of the aptamer (Fig. 2A). In a recent study of
the Gaur lab, the theophylline aptamer was placed close to the
branch point [46]. In the presence of theophylline, the downstream
exon was skipped two times more frequently in HeLa cells than in
the absence of theophylline indicating that engineered riboswitch-
es, besides regulating gene expression, can also be used to modu-
late and investigate the impacts of alternative splicing.
3.3. Control of translation initiation by riboswitches in bacteria
Engineered riboswitches have also been employed to control
gene expression in bacteria. Here, themechanism of translation ini-
tiationdiffers fromthat in eukaryotes and splicingdoesnot occur. As
a consequence, other essential elements have to be targeted. In pro-
karyotes, translation initiation is mediated by binding of the small
ribosomal subunit to the SD sequence, which is located in close
proximity to the start codon. As the distance betweenboth elements
is strictly coupled, riboswitches cannot be integrated between the
SD sequence and the start codon. Though, affecting the accessibility
of the SD sequence renders riboswitch based control of gene expres-
sion possible.
The Gallivan group has conducted exciting research in
engineering riboswitches in prokaryotes [47]. They inserted atheophylline aptamer upstream of the SD sequence of a lacZ gene
and varied the number and sequence of the nucleotides in be-
tween. Applying a genetic screen, they identiﬁed regulating se-
quences that lead to 36-fold induction of gene expression upon
the addition of theophylline. Structural analysis of the riboswitch
revealed that the selected sequences are involved in base pairing
with parts of the aptamer and thereby inhibit gene expression by
forcing the SD sequence in a helical structure. Binding of theophyl-
line favours an alternative RNA folding that liberates the SD se-
quence and thereby enables gene expression consistent to the
mechanism of natural riboswitches. In following studies, they reg-
ulated the motility behaviour of E. coli by inserting engineered
riboswitches into the chemotaxis controlling gene cheZ [48,49]. Re-
cently, they developed a set of synthetic riboswitches that permit
conditional gene expression in Gram-negative and Gram-positive
bacteria including pathogenic species [50].
We have used an alternativeway in controlling bacterial transla-
tion initiation (Fig. 2E).We inserted a theophylline aptamer in com-
binationwith a communicationmodule directly upstream of the SD
sequence. In the absence of theophylline, the stem-loop structure of
the switch inhibits binding of the small ribosomal subunit to the SD
sequence due to its close proximity. Binding of theophylline induces
a structural rearrangement within the communication module and
shifts the stem-loop away from the SD sequence thereby allowing
translation initiation [51].
3.4. Conditional gene expression by allosterically regulated ribozymes
Controlling gene expression on posttranscriptional level can
also be facilitated by regulating the degradation rate of a desired
mRNA with allosteric self-cleaving ribozymes. As here species spe-
ciﬁc elements of transcription or translation are not involved, it is
Fig. 2. Aptamers used in engineered riboswitches. Depicted are 2D and 3D structures of the (A) tetracycline, (B) neomycin and (C) theophylline aptamer. Stems, bulges and
loops are indicated with P, B and L, respectively, and labelled with a colour code. Nucleotides involved in ligand binding are boxed in the 2D structure and speciﬁed in the 3D
structure. Ligands are represented in an atomic colour code. Carbons are labelled in green, oxygens in red, nitrogens in blue and chlorides in brown. Hydrogens are omitted for
clarity. Magnesium is indicated as a yellow ball. Additionally, minimer versions of the tetracycline aptamer with truncated P2 and L2 elements are illustrated. Note that that
the ligand depicted in the 3D structure of the neomycin aptamer is ribostamycin. It has been chosen for NMR studies as it shows a similar repression and binding proﬁle as
neomycin but superior spectral resolution due to its smaller size. 3D structures were created with UCSF Chimera using pdb ID´s 3EGZ, 1EHT and 2KXM.
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example of a self-cleaving ribozyme being triggered by a small
molecule in vitro relied on the minimal hammerhead ribozyme
and was developed by Breaker and co-workers [35]. They fused
an ATP aptamer via rational design to the ribozyme and observed
that hammerhead cleavage can be both allosterically induced and
inhibited. With a linked theophylline aptamer, however, they re-
port only cleavage inhibition. In further studies, they combined ra-
tional design with various selection strategies. In one example,
they linked an aptamer and a ribozyme via a randomized domain
and selected communication modules suitable for allosteric ribo-
zyme regulation [36]. In another approach, they fused a previously
identiﬁed communication module to the hammerhead ribozyme
and randomized the aptamer domain to select new ligand speciﬁc
sensing domains [52]. Despite these and other promising studies,
aptazymes based on the minimal hammerhead ribozyme turned
out to be not optimal for cellular applications. The minimal
hammerhead ribozyme lacks sequences of the natural hammer-
head ribozyme that mediate tertiary loop-loop interactions
(Fig. 3), an absolute requirement for proper hammerhead folding
and, hence, catalysis at physiological magnesium concentrations
[53–55].
Mulligan and co-workers showed in an exciting study that, when
inserting the full-length hammerhead ribozyme at different posi-tions of a eukaryotic mRNA, autocatalytic cleavage of the ribozyme
resulted in destabilization and subsequent degradation of the corre-
sponding mRNA molecule leading to a reduced reporter gene
expression in mice [56]. In a follow-up study, a high-throughput
screening assay was carried out in order to ﬁnd small molecule
inhibitors of the hammerhead ribozyme thatwould allow the appli-
cation of the ribozyme for conditional gene expression [57]. Fifteen
compounds were identiﬁed that induce gene expression; the most
potent ones were nucleoside analogs. Studies of the mechanism of
action revealed that the identiﬁed compounds have to be incorpo-
rated into the RNA in order to inhibit ribozyme cleavage. However,
this unspeciﬁc mechanism led to cytotoxic effects rendering the se-
lected inhibitors inapplicable. Aptazymes based on the full-length
hammerhead ribozyme have been applied to regulate gene expres-
sion in both bacteria and eukaryotes. In a rational design approach,
the Smolke lab combined a theophylline aptamer with the full-
length hammerhead ribozyme and observed both ligand dependent
induction and inhibition of reporter gene expression in yeast [58].
Additionally, they demonstrated the modularity of this approach
by exchanging the theophylline aptamer with the tetracycline apt-
amer and successfully transferring both designs tomammalian cells
[59]. Hartig and co-workers developed small molecule responsive
aptazymes to control gene expression in bacteria. They sequestered
the SD sequence by integrating it into the hammerhead folding;
Fig. 3. A hammerhead ribozyme used in engineered riboswitches. Depicted are the 2D and 3D structure of the Schistosoma mansonii hammerhead ribozyme. The RNA strand
that gets cleaved is marked from S1 to S20 (the arrow in the 2D structure indicates the cleavage site) whereas the uncleaved strand is marked from 1 to 44. Stems, bulges,
loops and internal loops are indicated with P, B, L and IL, respectively, and labelled with a colour code. Nucleotides involved in the internal transesteriﬁcation reaction are
circled in the 2D structure and speciﬁed in the 3D stricture (G20 and G36 are thought to function as the general acid and base, respectively, and CS6 is the nucleotide after
which the RNA backbone is cleaved). Nucleotides involved in the long distance interaction between stem PI and PII are boxed in the 2D structure and speciﬁed in the 3D
structure. The 3D structure was created with UCSF Chimera using pdb ID 2GOZ.
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tion. In vivo screening resulted in optimized communication mod-
ules for a linked theophylline aptamer to trigger hammerhead
cleavage allosterically [60,61]. The switches selected for bacterial
applications turned out to regulate gene expression in mammalian
reporter systems as well [62].
Recently, we used a directed evolution approach to develop tet-
racycline responsive aptazymes suitable for conditional gene
expression in mammals [63]. To this end, we randomized the lin-
ker domain between the Schistosoma mansonii hammerhead ribo-
zyme (Fig. 3) and the minimer II version of the tetracycline
aptamer (Fig. 2A) and, different to the previously reported ap-
proaches, applied SELEX under physiological conditions to identify
communication modules optimized for the subsequent application
within cells. Whereas the isolated switches exhibit promising
cleavage characteristics under in vitro conditions, they regulate re-
porter gene expression only moderately in yeast and show no
cleavage activity in mammalian cells. Consequently, we performed
a 96-well based, dual reporter gene screening assay of 1152 indi-
vidual clones in mammalian cells (unpublished data). None of
the tested switches, however, reduced reporter gene expression
in a signiﬁcant and reproducible manner upon addition of tetracy-
cline indicating that more stringent conditions might have been
needed in the in vitro selection. Alternatively, performing in vitro
selection in crude cell extract or screening the RNA pool directly
in cells might overcome the limitations of in vitro selection [64].
3.5. Control of transcription by engineered riboswitches
Besides controlling gene expression on translational level, there
also exist a few examples of engineered riboswitches acting ontranscription. Liu and co-workers identiﬁed RNA sequences that
either mediate the recruitment of transcriptional activators or
silencers to the promoter of a selection marker using yeast three
hybrid screens [65,66]. They fused an activating RNA sequence
with a tetramethylrosamine aptamer thereby generating an tran-
scriptional activating riboswitch [67].
We have identiﬁed an aptamer that induces transcription in
E. coli [68]. We performed in vitro selection against TetR, a bacterial
repressor protein. A subsequent in vivo screening resulted in an
aptamer that activates TetR controlled gene expression. We have
shown that the aptamer actively replaces TetR from the operator
DNA by direct competition with the helix-turn-helix motif of the
repressor protein [69]. In a recent study, a fusion of the TetR apt-
amer with the theophylline aptamer was successfully used to trig-
ger the expression of a TetR controlled reporter gene by addition of
theophylline in mammalian cells [70].
4. Structural and mechanistic insights into engineered
riboswitches
4.1. What renders an aptamer into a riboswitch – the neomycin
aptamer
A major advantage of RNA-based genetic switches is the possi-
bility to combine sensing, transmitting and regulating domains
within one molecule and, thereby, to engineer synthetic molecules
with desired functions. In principle, aptamers can be generated
against any ligand of choice. However, it turned out that only
few aptamers have the potential to be exploited as sensing do-
mains for the engineering of riboswitches (discussed in detail later
in this section). Despite the fact that several dozen small molecule
Fig. 4. Mechanistic insights into the neomycin aptamer. Depicted is the 2D
structure of the neomycin aptamer in the free (left) and in the ligand bound state
(right). Upon neomycin binding, three new base pairs are formed (G9-C22, U10-
U21, U13-U18, labelled in blue), the extended upper helix stacks onto the closing
stem (indicated by a red arrow) and three nucleotides on the 50-side of the
asymmetric loop are bulged out (labelled in red).
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been used in riboswitch applications. Moreover, most studies re-
quired high ligand concentrations that affected cell viability to
some extend making most engineered riboswitches reported so
far not applicable. De facto, only the theophylline and the tetracy-
cline aptamer have been applied in a broader range.
We have been interested in the question why so many aptamers
fail in engineering and what turns an aptamer into a riboswitch. To
tackle this question, we performed a GFP-based in vivo screen for
regulating aptamers using an in vitro selected aptamer pool that
binds the aminoglycoside neomycin [41,71]. We identiﬁed an apt-
amer, N1, that confers neomycin depended control of translation
initiation in yeast (Fig. 2B). However, the N1 sequence was not
among those sequenced after the ﬁnal in vitro selection step (i)
indicating that the regulating aptamer was underrepresented in
the in vitro selected aptamer pool and (ii) emphasising the impor-
tance of an in vivo screening step for the identiﬁcation of regulat-
ing aptamers. Interestingly, both the dominant aptamer sequence
after in vitro selection, R23 (which did not regulate), and the reg-
ulating aptamer N1 show a comparable high afﬁnity binding to
neomycin in the lower nanomolar range indicating that afﬁnity is
not sufﬁcient to confer regulation [41,71,72]. This raised the ques-
tion what distinguishes regulating from non-regulating aptamers
and what are the molecular determinants that render an aptamer
into a riboswitch.
The aptamer N1 is with 27 nucleotides the smallest riboswitch
reported so far. It is comprised of an internal asymmetric and a ter-
minal loop dissected by two GC base pairs (Fig. 2B). Mutational
analysis and structural probing indicated that both loops are
important for ligand binding, however, only the lower part of the
internal loop is important for regulation. A saturating mutagenesis
of this region resulted in an interesting ﬁnding: Regulation is only
possible if the asymmetry in the lower part of the loop is main-
tained in a way that one to four nucleotides, independent of the se-
quence, at the 50 side (coloured red in Fig. 4) are facing no
nucleotide at the 30 side. Thus, a bulge at the 50 side seems to confer
regulation. NMR spectroscopy allowed us a deeper insight into the
regulatory mechanism [73]. It revealed that the aptamer is less
structured in absence of the ligand with only the closing stem
and the two GC pairs being formed. Upon ligand binding, extensive
conformational changes occur and the upper helix is extended by
three additional base pairs (coloured blue in Fig. 4). The nucleo-
tides at the 50 part of the internal loop are bulged out and allow
stacking of the extended upper helix directly onto the closing stem
thereby driving the bulge out. The ligand neomycin acts like a
clamp locking the upper and the lower helix. This turns the apt-
amer into the ‘‘roadblock’’ competent conformation comprising a
continuous A-form helix topped by a structured terminal loop
and a highly dynamic internal bulge (Fig. 4). Thus, this bulge rep-
resents a structural element that confers regulation by destabiliza-
tion of the ligand free state of the aptamer.
Interestingly, all non-regulating aptamers show a completely
different behaviour. Here, NMR spectra of the free and the ligand
bound conformation are quite similar indicating that no major con-
formational changes occur upon ligand binding [72,74]. This ﬁnd-
ing indicates that an open ground state accompanied by
signiﬁcant ligand induced conformational changes is important
for regulation. This is also reﬂected by the fact that regulating apta-
mers are signiﬁcantly more stabilized upon ligand binding than
inactive variants indicating that thermal stabilization is an impor-
tant determinant for riboswitch activity.
NMR experiments with the neomycin aptamer N1 performed at
lower temperatures unravelled that the structural ensemble of the
free state also contains a population of aptamers that is structur-
ally very similar to the bound conformation. This population in-
creases with decreasing temperature [73]. This ﬁts data obtainedby EPR spectroscopy. Here, inter spin distance measurements in
the absence and presence of neomycin monitored at very low tem-
peratures (50 K) showed no signiﬁcant differences between the
free and the bound form of the aptamer indicating the complete
population shifted towards the conformation that resembles the
bound state [75]. Both NMR and EPR data indicate a binding mech-
anism that involves conformational capture where the ligand se-
lects the preformed bound conformation from the ensemble of
the free RNAs.
4.2. The tetracycline aptamer – a sophisticated gene regulatory
element
The tetracycline aptamer is twice as large as the neomycin apt-
amer and is comprised of three helices (stems P1, P2, P3), the single
stranded regions B1–2, B2–3 and the loop L3 (Fig. 2A). Mutational
analysis and structural probing of the two separate single stranded
regions B1–2 and L3 showed that both are important for ligand
binding [76]. All stems and the domain on top of stem P2 are al-
ready formed in the absence of the ligand. They are not part of
the binding pocket and therefore their sequence is variable.
A high resolution structure of the aptamer-ligand-complex
showed that stem P3 stacks on the closing stem P1 [77]. Stem P2
stacks on an irregular helix comprised of the single-stranded junc-
tions B1–2 and B2–3. Further on, nucleotides of the loop L3 interact
with this irregular helix providing an intricate binding pocket for
tetracycline (Fig. 2A). The tetracycline aptamer has the highest
binding strength of a small molecule-binding aptamer reported
so far (770 pM) [78]. Mutational analysis demonstrated that even
a slight reduction in binding strength (1–3 nM) led to gene regula-
tion only half as efﬁcient.
The highly complex architecture of the binding pocket, which is
stabilized by long range interactions, is reminiscent of natural
riboswitches [77]. Like the purine riboswitches, the tetracycline
aptamer harbours its ligand in a three-way junction. These com-
plex binding pockets close over the ligand, nearly enveloping it
completely. In comparison, other small molecule binding aptamers
such as the neomycin and the theophylline aptamer are often just
comprised of a single helical stack with the ligand surrounded by
irregular elements at the junction of two helices (Fig. 2B, C) [33].
The tetracycline aptamer is pre-structured in the absence of the
ligand [76]. Extensive global changes within the aptamer upon li-
gand binding have been excluded by EPR spectroscopy [79]. Inter-
spin distance measurements of doubly spin labelled aptamers
rather indicate the presence of a dynamic equilibrium between
2082 A. Wittmann, B. Suess / FEBS Letters 586 (2012) 2076–2083two conformations in the absence of the ligand and a capture of
one conformation upon tetracycline binding. Ligand binding occurs
as a very fast two-step mechanism, which can be interpreted as a
binding step in which contacts to both single stranded regions
B1–2 and L3 are made followed by a reorganization of the aptamer
to tightly accommodate the ligand [80].
The fast binding may be important for the aptamer’s regulatory
activity. mRNAs exist as ribonucleoprotein particles within cells.
Therefore the ligand tetracycline has to compete with RNA associ-
ated proteins. The aptamer might not be available for ligand bind-
ing most of the time due to the interference of proteins with
preformation of the binding pocket. Hence, a fast association of tet-
racycline to the RNA is important for complex formation. In addi-
tion, a long lifetime of the complex is favourable, which explains
the need for a high binding afﬁnity.
5. Conclusion and future perspectives
Within this reviewwehave outlined that engineered riboswitch-
es are RNA-based genetic devices capable of regulating various steps
of gene expression. Our mechanistic studies have revealed that
aptamers are applicable as riboswitches if they exhibit three essen-
tial characteristics: First, the aptamer must bind its ligand with a
very high afﬁnity. Second, a conformational change upon ligand
binding has to occur. Third, the association of the ligand to the apt-
amer has to be fast. Aptamer domains are usually generated via
in vitro selection. As only the high afﬁnity of an aptamer can be ad-
dressed by the setup of in vitro selection,we consider in vivo screen-
ing as amandatory step to identify aptamers suitable for riboswitch
applications. Despite the fact that engineered riboswitches have
been developed successfully using rational design, the combination
of in vitro selection and in vivo screening is a powerful way to result
more likely in switches optimized for cellular applications.
Recent studies reported high-throughput in vivo screenings and
selections for the identiﬁcation of engineered riboswitches. The
screening approaches are based on ﬂuorescent activated cell sort-
ing (FACS) whereas the selection approaches employ cell motility
or genetic selection markers [81–84]. On contrary to the FACS
based screening assays, the selections via cell motility or survival
are methodically rather simple and not nearly as expensive. Never-
theless, both in vivo screening and selection approaches facilitate
high-throughput applications and should speed up the developing
process of engineered riboswitches.
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